Long-acting beta2-agonists versus theophylline for maintenance treatment of asthma.

Tee, A K H; Koh, M S; Gibson, P G; Lasserson, T J; Wilson, A J; Irving, L B

Tee, A K H; Koh, M S; Gibson, P G; Lasserson, T J; Wilson, A J; Irving, L B.

Affiliation

Tee AK; Royal Melbourne Hospital, Respiratory & Sleep Medicine, Grattan Street, Parkville, Melbourne, Victoria, Australia, 3050. Augustine.Tee@mh.org.au

Cochrane Database Syst Rev ; (3): CD001281, 2007 Jul 18.

Article in En | MEDLINE | ID: mdl-17636663

Subject(s)

Adrenergic beta-Agonists/therapeutic use; Albuterol/analogs & derivatives; Asthma/prevention & control; Bronchodilator Agents/therapeutic use; Theophylline/therapeutic use; Adult; Albuterol/therapeutic use; Asthma/drug therapy; Delayed-Action Preparations; Humans; Randomized Controlled Trials as Topic

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Theophylline / Bronchodilator Agents / Adrenergic beta-Agonists / Albuterol Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Systematic_reviews Limits: Adult / Humans Language: En Journal: Cochrane Database Syst Rev Journal subject: PESQUISA EM SERVICOS DE SAUDE Year: 2007 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google